SK

Sanjeev Kumar

Active Director Director DIN 06457367
DIN 06457367 First appointment Jan 2013 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2013
Shareholding value •••• Premium profile

About Sanjeev Kumar

Data last updated:

Sanjeev Kumar is a Director at Debel Pharmaceuticals Private Limited (since 2013). The company operates in Chemicals. Debel Pharmaceuticals Private Limited reported revenue of ₹4.9 Lakh (FY 2025).

DIN 06457367
Primary Designation Director
Industry Chemicals
First Appointment 16 Jan 2013
Oldest Company Age 13 yrs
Largest company Debel Pharmaceuticals Private Limited · ₹4.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20132013₹4.9 Lakh (FY 2025)Active

Board colleagues of Sanjeev Kumar

NameDINCompanyDesignation
Anita07542622Debel Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Debel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sanjeev Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjeev Kumar

Sanjeev Kumar currently holds 1 directorship: Debel Pharmaceuticals Private Limited (Director, since 16 Jan 2013, revenue ₹4.9 Lakh (FY 2025)).

Sanjeev Kumar was first appointed on 16 Jan 2013 as Director at Debel Pharmaceuticals Private Limited.

The current boards of Sanjeev Kumar's companies include Anita (Debel Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available